Literature DB >> 883822

Comparison of pharmacological and antimicrobial properties of cefadroxil and cephalexin.

A I Hartstein, K E Patrick, S R Jones, M J Miller, R E Bryant.   

Abstract

Pharmacological and antimicrobial properties of cefadroxil, a new cephalosporin antibiotic, were compared with cephalexin. Absorption and excretion were studied in 20 healthy men. Peak concentrations of the drugs in serum were similar after ingestion of single 500-mg tablets. The concentration of cefadroxil in serum was more sustained than that of cephalexin. Levels of cefadroxil in serum after a dose of 1,000 mg were approximately twice those after a 500-mg dose through 6 h. Each drug administered in a dose of 500 mg every 6 h for 24 h resulted in concentrations in serum that were similar to a single dose without accumulation. Ninety-three percent of the cefadroxil and 85% of the cephalexin were excreted in urine after ingestions of single 500-mg tablets. The urine concentration of cefadroxil was more sustained than cephalexin. Minimal inhibitory and minimal bactericidal concentrations for clinical isolates were comparable with each drug. Cefadroxil compares favorably with cephalexin in this study. Sustained levels of cefadroxil in serum and urine suggest that this drug may be given at less frequent intervals than cephalexin.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 883822      PMCID: PMC352159          DOI: 10.1128/AAC.12.1.93

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  13 in total

1.  LABORATORY AND CLINICAL EVALUATION OF A NEW ANTIBIOTIC--CEPHALOTHIN.

Authors:  M TURCK; K N ANDERSON; R H SMITH; J F WALLACE; R G PETERSDORF
Journal:  Ann Intern Med       Date:  1965-08       Impact factor: 25.391

2.  Bacteriuria localization and response to single-dose therapy in women.

Authors:  A R Ronald; P Boutros; H Mourtada
Journal:  JAMA       Date:  1976-04-26       Impact factor: 56.272

3.  Antibiotic sensitivity testing. Report of an international collaborative study.

Authors:  H M Ericsson; J C Sherris
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1971

4.  Serum versus urinary antimicrobial concentrations in cure of urinary-tract infections.

Authors:  T A Stamey; W R Fair; M M Timothy; M A Millar; G Mihara; Y C Lowery
Journal:  N Engl J Med       Date:  1974-11-28       Impact factor: 91.245

5.  The significance of sensitivity tests of Staphylococcus aureus to cephaloridine.

Authors:  S M Bell
Journal:  Med J Aust       Date:  1974-12-21       Impact factor: 7.738

6.  The use of balanced incomplete block designs in comparative bioavailability trails.

Authors:  W J Westlake
Journal:  Biometrics       Date:  1974-06       Impact factor: 2.571

7.  Comparative human oral clinical pharmacology of cefadroxil, cephalexin, and cephradine.

Authors:  M Pfeffer; A Jackson; J Ximenes; J P de Menezes
Journal:  Antimicrob Agents Chemother       Date:  1977-02       Impact factor: 5.191

8.  How well do patients take oral penicillin? A collaborative study in private practice.

Authors:  E Charney; R Bynum; D Eldredge; D Frank; J B MacWhinney; N McNabb; A Scheiner; E A Sumpter; H Iker
Journal:  Pediatrics       Date:  1967-08       Impact factor: 7.124

9.  Single daily doses of tobramycin in therapy of urinary tract infections.

Authors:  R R Landes
Journal:  J Infect Dis       Date:  1976-08       Impact factor: 5.226

10.  Cefadroxil, a new broad-spectrum cephalosporin.

Authors:  R E Buck; K E Price
Journal:  Antimicrob Agents Chemother       Date:  1977-02       Impact factor: 5.191

View more
  7 in total

1.  Influence of peptide transporter 2 (PEPT2) on the distribution of cefadroxil in mouse brain: A microdialysis study.

Authors:  Xiaomei Chen; Richard F Keep; Yan Liang; Hao-Jie Zhu; Margareta Hammarlund-Udenaes; Yongjun Hu; David E Smith
Journal:  Biochem Pharmacol       Date:  2017-02-10       Impact factor: 5.858

2.  Comparative pharmacokinetics of cephalexin, cefaclor, cefadroxil, and CGP 9000.

Authors:  H Lode; R Stahlmann; P Koeppe
Journal:  Antimicrob Agents Chemother       Date:  1979-07       Impact factor: 5.191

3.  Population pharmacokinetic modeling of cefadroxil renal transport in wild-type and Pept2 knockout mice.

Authors:  Yehua Xie; Hong Shen; Yongjun Hu; Meihua Rose Feng; David E Smith
Journal:  Xenobiotica       Date:  2015-09-15       Impact factor: 1.908

4.  Interethnic differences of PEPT2 (SLC15A2) polymorphism distribution and associations with cephalexin pharmacokinetics in healthy Asian subjects.

Authors:  Rui Liu; Audrey May Yi Tang; Yen Ling Tan; Lie Michael George Limenta; Edmund Jon Deoon Lee
Journal:  Eur J Clin Pharmacol       Date:  2008-09-03       Impact factor: 2.953

Review 5.  Cefadroxil. A review of its antibacterial, pharmacokinetic and therapeutic properties in comparison with cephalexin and cephradine.

Authors:  B Tanrisever; P J Santella
Journal:  Drugs       Date:  1986       Impact factor: 9.546

6.  Clinical pharmacology of cefadroxil in infants and children.

Authors:  C M Ginsburg; G H McCracken; J C Clahsen; M L Thomas
Journal:  Antimicrob Agents Chemother       Date:  1978-05       Impact factor: 5.191

7.  Cefadroxil Comparable to Cephalexin: Minimum Inhibitory Concentrations among Methicillin-Susceptible Staphylococcus aureus Isolates from Pediatric Musculoskeletal Infections.

Authors:  Andrew S Haynes; Andrea Prinzi; Lori J Silveira; Sarah K Parker; Jed N Lampe; Jeffrey S Kavanaugh; Alexander R Horswill; Douglas Fish
Journal:  Microbiol Spectr       Date:  2022-06-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.